Calcium channel blockers - The jury is still out on whether they cause heart attacks and suicide

被引：30

作者：

Stanton, AV ^{[1
]}

机构：

[1] St Marys Hosp, Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Clin Pharmacol & Epidemiol, London W2 1NY, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7143期

关键词：

D O I：

10.1136/bmj.316.7143.1471

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1471 / 1473

页数：3

共 13 条

[1] Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) - A randomized controlled trial [J].

Borhani, NO ;

Mercuri, M ;

Borhani, PA ;

Buckalew, VM ;

CanossaTerris, M ;

Carr, AA ;

Kappagoda, T ;

Rocco, MV ;

Schnaper, HW ;

Sowers, JR ;

Bond, MG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (10) :785-791

[2] Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events [J].

Byington, RP ;

Craven, TE ;

Furberg, CD ;

Pahor, M .

LANCET, 1997, 350 (9084) :1075-1076

[3] The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension [J].

Estacio, RO ;

Jeffers, BW ;

Hiatt, WR ;

Biggerstaff, SL ;

Gifford, N ;

Schrier, RW .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :645-652

[4] Use of calcium channel blockers and risk of suicide:: ecological findings confirmed in population based cohort study [J].

Lindberg, G ;

Bingefors, K ;

Ranstam, J ;

Råstam, L ;

Melander, A .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7133) :741-745

[5]

MULDOON MF, 1991, NEW ENGL J MED, V324, P922

[6] Treatment of hypertensive patients with diabetes [J].

Pahor, M ;

Psaty, BM ;

Furberg, CD .

LANCET, 1998, 351 (9104) :689-690

[7] LONG-TERM SURVIVAL AND USE OF ANTIHYPERTENSIVE MEDICATIONS IN OLDER PERSONS [J].

PAHOR, M ;

GURALNIK, JM ;

CORTI, MC ;

FOLEY, DJ ;

CARBONIN, P ;

HAVLIK, RJ .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (11) :1191-1197

[8]

PEDERSEN TR, 1994, LANCET, V344, P1383

[9] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[10] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

← 1 2 →